Zulvac 8 Bovis
inactivated bluetongue virus, serotype 8
Table of contents
Withdrawn
This medicine is now withdrawn from use in the European Union.
Overview
The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.
This EPAR was last updated on 24/11/2020
Authorisation details
| Product details | |
|---|---|
| Name |
Zulvac 8 Bovis
|
| Agency product number |
EMEA/V/C/000145
|
| Active substance |
inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02
|
| International non-proprietary name (INN) or common name |
inactivated bluetongue virus, serotype 8
|
| Species |
Cattle
|
| Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI02AA08
|
| Publication details | |
|---|---|
| Marketing-authorisation holder |
Zoetis Belgium SA
|
| Revision |
7
|
| Date of issue of marketing authorisation valid throughout the European Union |
15/01/2010
|
| Contact address |
Zoetis Belgium SA |
Product information
23/03/2017 Zulvac 8 Bovis - EMEA/V/C/000145 - IG/0747
Contents
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pharmacotherapeutic group
Pharmacotherapeutic group
Immunologicals
Therapeutic indication
Therapeutic indication
Active immunisation of cattle from three months of age for the prevention of viraemia caused by bluetongue virus, serotype 8.